Accueil / Tag Archives: California

Tag Archives: California

American Shared Hospital Services Reports Second Quarter Results

Thursday, August 10th 2017 at 12:03pm UTC SAN FRANCISCO–(BUSINESS WIRE)– AMERICAN SHARED HOSPITAL SERVICES (NYSE AMERICAN: AMS) (the « Company »), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the second quarter and first six months of 2017. Second Quarter Results …

Plus »

DJO Global Announces Financial Results for Second Quarter 2017

Thursday, August 10th 2017 at 8:05pm UTC Business Transformation on Schedule SAN DIEGO–(BUSINESS WIRE)– DJO Global, Inc. (“DJO” or the “Company”), a leading global provider of medical technologies designed to get and keep people moving, today announced financial results for its public reporting subsidiary, DJO Finance LLC (“DJOFL”), for the …

Plus »

Codexis Obtains Court Order Awarding Summary Judgment of Patent Infringement against EnzymeWorks

Tuesday, August 8th 2017 at 8:38pm UTC REDWOOD CITY, Calif.–(BUSINESS WIRE)– Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, on Tuesday secured a federal court order awarding it summary judgment on 10 claims of patent infringement it brought in a lawsuit against Suzhou, China-based EnzymeWorks, Inc. and its San …

Plus »

NantHealth Reports 2017 Second Quarter Financial Results; Implements Plan to Focus on Core Competencies, Enhance Profitability and Position for Growth of Artificial Intelligence for Cancer Care

Thursday, August 10th 2017 at 8:15pm UTC Restructuring Plan Implemented To Focus on Cancer Decision Support and Artificial Intelligence Platform Integration of Four Pillars: GPS Cancer, Eviti Clinical Decision Support, Connected Care and Provider/Payer Engagement Sale of Patient/Provider Portal to Allscripts Expected to Significantly Accelerate Timeline to Profitability Synergies of …

Plus »

Heron Therapeutics Reports Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress

Wednesday, August 9th 2017 at 8:20pm UTC -Strong SUSTOL Sales; Guidance Increased for 2017- SAN DIEGO, Calif.–(BUSINESS WIRE)– Heron Therapeutics, Inc. (Nasdaq: HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of the most important unmet patient needs, today reported financial …

Plus »

AgeX Therapeutics CEO Michael D. West, Ph.D. to Deliver Keynote Address on Biotechnology and Aging at RAAD Festival

Wednesday, August 9th 2017 at 11:00am UTC ALAMEDA, Calif.–(BUSINESS WIRE)– AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today that CEO Michael D. West, Ph.D., will deliver the keynote presentation at the RAAD Festival 2017 (RAADfest), a large annual gathering of life extension experts, August 9-13, …

Plus »

Gilead Announces U.S. FDA Priority Review Designation for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV

Thursday, August 10th 2017 at 8:01pm UTC — Final FDA Decision Anticipated by February 12, 2018 — FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New Drug Application (NDA) for an investigational, …

Plus »

CA Legislators Told of Biological & Health Risks from Pervasive 4G/5G Wireless Antennas Envisioned by SB.649

Wednesday, August 9th 2017 at 3:46pm UTC —Similar Legislation Facilitating Massive New Wireless Radiation Emissions is Underway in Other States and Washington, D.C. WASHINGTON–(BUSINESS WIRE)– Martin Pall, Ph.D., Professor Emeritus of Biochemistry and Basic Medical Sciences at Washington State University, has notified California state legislators of the risks involved in …

Plus »

Heron Therapeutics Announces Initiation of Phase 3 Program for HTX-011 in Postoperative Pain Following Successful End-of-Phase 2 Meeting with FDA

Wednesday, August 9th 2017 at 8:05pm UTC -Phase 3 Program Expected to Enable Broad Indication- -NDA Filing Planned for 2018- -Final Phase 2 Results Demonstrate Clear Superiority to Bupivacaine Solution across All Surgical Models Evaluated- -Conference Call and Webcast Today at 5:00 p.m. ET- SAN DIEGO–(BUSINESS WIRE)– Heron Therapeutics, Inc. …

Plus »

Trufa Honored with Red Dot Award: Communication Design 2017

Thursday, August 10th 2017 at 3:05pm UTC SAN BRUNO, Calif. & HEIDELBERG, Germany–(BUSINESS WIRE)– Trufa is proud to announce that its enterprise performance application received the prestigious Red Dot Award: Communication Design 2017. The winning team combined Silicon Valley design and German Engineering: Design agency NONOBJECT, Palo Alto CA and …

Plus »
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cuZWVpLWJpb3RlY2hmaW5hbmNlcy5jb20vd3AtY29udGVudC91cGxvYWRzLzIwMTUvMDcvU2F0cmEtMi5tcDQiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...